首页> 外文期刊>Vaccine >One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination
【24h】

One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination

机译:非人类灵长类动物的一次性基因枪或肌内狂犬病DNA疫苗接种:接种疫苗1年后中和抗体反应和针对狂犬病毒的保护作用的比较

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously shown that Macaca fascicularis (Cynomologus) monkeys receiving a primary and either one or two booster rabies DNA vaccinations are protected against rabies virus. In this study, we determined whether monkeys that had been vaccinated only once via gene gun or intramuscularly (i.m.) with different concentrations of DNA would be protected against rabies virus challenge. Neutralizing antibody responses were assayed for I year before the monkeys were challenged. Neutralizing antibody was detected at least 50 days earlier in gene gun vaccinated as compared to i.m. vaccinated animals. Prior to viral challenge, all (6/6, 100%) gene gun vaccinated animals, but only 3/6 (50%) i.m. vaccinated animals seroconverted In general, antibody titers of the gene gun vaccinated animals were higher than the titers of the i.m. vaccinated animals. There was no correlation between the concentration of DNA used for vaccination, the neutralizing antibody responses elicited and protection against viral challenge. Seven days after viral challenge, a rapid and strong anamnestic antibody response Was elicited in 100% of the gene gun vaccinated monkeys and in four i.m. vaccinated monkeys. Neutralizing antibody remained undetectable in two i.m. vaccinated monkeys. Overall, 60% (3/5) of the gene gun vaccinated animals and 87% (5/6) of the i.m. vaccinated monkeys survived viral challenge. This study is the first, to our knowledge, to show long-term protection of non-human primates against a human viral pathogen using a DNA vaccination protocol that did not include a booster immunization.
机译:先前我们已经表明,接受初次和一次或两次加强狂犬病DNA疫苗接种的猕猴(猴)猴子可以抵抗狂犬病毒。在这项研究中,我们确定了仅通过基因枪或肌肉内(i.m.)接种了一次不同浓度的DNA的猴子是否可以抵抗狂犬病毒攻击。在攻击猴子之前的1年中测定中和抗体应答。与免疫接种相比,在接种疫苗的基因枪中至少提前50天检测到中和抗体。接种动物。在进行病毒攻击之前,所有(6/6,100%)基因枪都给动物接种了疫苗,但当天下午只有3/6(50%)。总体而言,基因枪疫苗接种动物的抗体效价高于免疫接种动物的抗体效价。接种动物。用于疫苗接种的DNA浓度,引起的中和抗体反应与抗病毒攻击的保护之间没有相关性。病毒攻击后第7天,在100%接受基因枪疫苗接种的猴子中和在4例腹泻中引发了快速而强烈的记忆消除抗体反应。接种猴子。中和抗体在两个下午仍然无法检测到。接种猴子。总体而言,有60%(3/5)的基因枪为动物接种了疫苗,而i.m.的87%(5/6)则为动物注射了疫苗。接种疫苗的猴子在病毒攻击后存活下来。据我们所知,这项研究是首次显示使用不包括加强免疫的DNA疫苗接种方案对人类非人类灵长类动物进行长期保护。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号